The company recently learned that the USPTO has granted another invention patent to Attobio

Attobio2019-06-19

On June 17, 2019, the company learned that the USPTO has granted another invention patent (patent name: HPV-related fusion protein and applications thereof) to Itokin, with the authorization number of us 10329328b2.

This is another important new intellectual property right after the company obtained 17 invention patents approved by China and international PCT patent organizations. It is of great significance for the company to continue to consolidate its technological innovation ability, establish a strong intellectual property system, and make great progress in technological innovation and market leadership.